TPCO Holding (TPCO Holding) EBITDA Margin % : -65.40% (As of Mar. 2023)

View and export this data going back to 2020. Start your Free Trial

What is TPCO Holding EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. TPCO Holding's EBITDA for the three months ended in Mar. 2023 was $-11.81 Mil. TPCO Holding's Revenue for the three months ended in Mar. 2023 was $18.05 Mil. Therefore, TPCO Holding's EBITDA margin for the quarter that ended in Mar. 2023 was -65.40%.

TPCO Holding EBITDA Margin % Historical Data

The historical data trend for TPCO Holding's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TPCO Holding EBITDA Margin % Chart

TPCO Holding Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

EBITDA Margin %

-597.00

-264.17

TPCO Holding Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
EBITDA Margin %	Get a 7-Day Free Trial									-113.47	-81.11	-748.14	-136.80	-65.40

Competitive Comparison of TPCO Holding's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, TPCO Holding's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TPCO Holding's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TPCO Holding's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where TPCO Holding's EBITDA Margin % falls into.

TPCO Holding EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

TPCO Holding's EBITDA Margin % for the fiscal year that ended in Dec. 2022 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-220.943	/	83.637
	=	-264.17 %

TPCO Holding's EBITDA Margin % for the quarter that ended in Mar. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Mar. 2023 )	/	Revenue (Q: Mar. 2023 )
	=	-11.807	/	18.054
	=	-65.40 %

TPCO Holding (OTCPK:GRMWF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

TPCO Holding EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of TPCO Holding's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

TPCO Holding (TPCO Holding) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TPCO Holding Corp (OTCPK:GRMWF) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1550 Leigh Avenue, San Jose, CA, USA, 95125

Website

https://www.theparent.co

TPCO Holding Corp is a consumer-focused cannabis company based in the United States focused on the recreational and wellness markets. Its operational footprint spans cultivation, extraction, manufacturing, distribution, brands, retail and delivery. The company's sales channels include Direct Consumer and Wholesale, of which key revenue is derived from the Wholesale channel which includes the company selling first-party and selected third-party products into 450 dispensaries across California. Additional wholesale revenue comes from sales of sourced bulk flowers and oil produced in-house. It has one segment engaged in the cultivation, manufacturing, distribution and sale of cannabis within the State of California.